About

Home page

Company Profile

Brand strategy

Company Profile

Founded in 2001, Qirui Technology Group is one of the comprehensive medical and health industry groups with leading comprehensive strength and scale in Hubei Province. health industry chain.

The Group firmly establishes and practices the core values of "Quality and Responsibility", promotes the continuous upgrading of operation model, talent incentives, organizational design and system construction, stimulates the vitality of various elements, and integrates global resources. The transformation of an international research enterprise.

MORE +

Brand Strategy

With the attitude of a pioneer, Keirui will actively carry out innovative R&D, strengthen its core competitiveness, uphold the core values of quality and responsibility, and step out of China and into the world!

Quality

GMP Certificate for Fasudil Mesylate

DGDA-1

DGDA-2

DGDA-3

MORE +

Development Path

2019

Fermentation platform Shandong Ruiyin Bioengineering Co., Ltd. was established and 1+3 innovative drugs received clinical approvals

2018

Received clinical approval and initiated first clinical study

2017

Submit your first IND application

2017

Comprehensive transformation from traditional management to information-based management, and advancement to the era of big data through information-based management

2014

Sofadone product launch

2014

Recertified by the new GMP

2013

Awarded national local joint research center and national postdoctoral workstation

2012

Fasudil mesylate injection/atorvastatin calcium launched

2011

Awarded the "12th Five-Year Plan" National Innovative Drug Incubation Base

2009

R&D-based production base for pharmaceutical raw materials established (Gedian Development Zone)

2009

Keirui Wuhan R&D Center established (Guanggu Biological City)

2008

Approved Enterprise Technology Center in Hubei Province

2008

Hubei Province was approved engineering technology research center

2007

The joint laboratory with Tongji passed the national GMP certification and was successfully put into production, and "Regan" series products were launched.

2005

Formulation production base established (Miaoshan Pharmaceutical Park)

2001

Qirui Technology (Group) was established

1998

The first azithromycin injection

发展历程

development path